V Square Quantitative Management LLC Raises Holdings in CVS Health Co. (NYSE:CVS)

V Square Quantitative Management LLC lifted its holdings in shares of CVS Health Co. (NYSE:CVS) by 16.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,347 shares of the pharmacy operator’s stock after purchasing an additional 2,586 shares during the period. V Square Quantitative Management LLC’s holdings in CVS Health were worth $824,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. AMF Tjanstepension AB lifted its holdings in shares of CVS Health by 124.1% during the 3rd quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock valued at $3,882,000 after acquiring an additional 34,198 shares in the last quarter. Exchange Traded Concepts LLC grew its position in shares of CVS Health by 61.9% during the 3rd quarter. Exchange Traded Concepts LLC now owns 14,853 shares of the pharmacy operator’s stock valued at $934,000 after buying an additional 5,679 shares during the last quarter. Creative Planning grew its position in shares of CVS Health by 23.5% during the 3rd quarter. Creative Planning now owns 250,891 shares of the pharmacy operator’s stock valued at $15,776,000 after buying an additional 47,737 shares during the last quarter. nVerses Capital LLC bought a new position in CVS Health in the 3rd quarter worth about $101,000. Finally, Secure Asset Management LLC grew its position in CVS Health by 38.4% in the 3rd quarter. Secure Asset Management LLC now owns 29,247 shares of the pharmacy operator’s stock worth $1,839,000 after purchasing an additional 8,121 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of research analyst reports. Leerink Partnrs raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Wednesday. Cantor Fitzgerald upgraded CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft raised CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price objective for the company in a research report on Tuesday, December 3rd. Piper Sandler reduced their price objective on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research report on Monday, November 25th. Finally, Barclays boosted their price target on CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $70.28.

CVS Health Price Performance

NYSE CVS opened at $65.71 on Friday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a market capitalization of $82.68 billion, a PE ratio of 16.68, a P/E/G ratio of 0.60 and a beta of 0.61. The stock has a 50-day simple moving average of $50.90 and a 200 day simple moving average of $56.01.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. Research analysts anticipate that CVS Health Co. will post 5.14 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were paid a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.05%. CVS Health’s dividend payout ratio is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.